Dr. Aditya Mehta, MD

Dr. Mehta practices at Mason Health - Mason Clinic-Primary Care in Shelton, Washington.

Dr. Mehta's NPI, 1679964324, was assigned on February 16, 2015. Dr. Mehta graduated from The University of New Mexico School of Medicine in 2015. Dr. Mehta's Nebraska license number on file is 29723.

Dr. Mehta's primary practice is Mason Health - Mason Clinic-Primary Care, at 1701 N 13th St, Shelton, WA 98584. The practice phone is (360) 426-2653.

Dr. Mehta's primary practice is Mason Health - Mason Clinic-Primary Care in Shelton, Washington. The medical group on file is Mason Health. Dmand AI also links Dr. Mehta to 3 more medical groups and 1 group practice or clinic, each named with a free account. Dr. Mehta's employer is on file too: a rural health clinic (rhc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehta practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Mehta's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Mehta is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Mehta's licenses on file in 6 states: Nebraska, Kentucky, Montana, New Mexico, Texas and Washington.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, glaucoma, inflammation of iris and retinal occlusion among the conditions Dr. Mehta treats.

CMS data shows 757 Medicare services from Dr. Mehta across 12 procedure codes in 2024, for 300 Medicare patients. Medicare paid $75,068 for them.

CMS counts 300 Medicare patients who saw Dr. Mehta in 2024. The largest group is 75 to 84, with 124 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mehta's median patient age at 71, with 57% women.

In 2024, Dr. Mehta wrote 110 Medicare Part D claims for 57 patients. 56% of them were for generic drugs. CMS names the drug for 68 of them, across 3 drugs with 11 or more claims each, at $1,225 in total drug cost. In 2023, CMS named 38 claims across 2 drugs.

Dmand AI links 12 papers to Dr. Mehta, published from 2018 to 2021. 2019 was the busiest year, with 5. The most frequent topics are Eye Enucleation, Eye Evisceration and Eye Injuries. Dr. Mehta has published most often in Am J Ophthalmol Case Rep. Dr. Mehta's most frequent co-authors are Donovan Stephen Reed, MD, Brett W. Davies, MD and Joseph A. Santamaria, MD.

CMS Open Payments shows 37 general payments to Dr. Mehta from 14 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 61% of the total. Abbott Laboratories paid the most, $1,599.

Dr. Mehta graduated from The University of New Mexico School of Medicine in 2015. Dr. Mehta is a member of AAO.

Dr. Mehta is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.